Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options

Author(s): Nicola Pescosolido, Federica Pranno, Giuseppe Buomprisco

Journal Name: Current Diabetes Reviews

Volume 9 , Issue 6 , 2013

Become EABM
Become Reviewer
Call for Editor


The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/ grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.

Keywords: Anti-VEGF, diabetic macular edema, diabetes, neovascularization, rethinopathy, vision loss prevention.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 13 November, 2013
Page: [491 - 498]
Pages: 8
DOI: 10.2174/15733998113096660083
Price: $65

Article Metrics

PDF: 37